As the global economy mends, the 2021 growth of Cardiac Monitoring & Cardiac Rhythm Management will have significant change from previous year. According to our (LP Information) latest study, the global Cardiac Monitoring & Cardiac Rhythm Management market size is USD million in 2022 from USD 23310 million in 2021, with a change of % between 2021 and 2022. The global Cardiac Monitoring & Cardiac Rhythm Management market size will reach USD 29910 million in 2028, growing at a CAGR of 3.6% over the analysis period.
The United States Cardiac Monitoring & Cardiac Rhythm Management market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cardiac Monitoring & Cardiac Rhythm Management market, reaching US$ million by the year 2028. As for the Europe Cardiac Monitoring & Cardiac Rhythm Management landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cardiac Monitoring & Cardiac Rhythm Management players cover Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, and Boston Scientific Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Monitoring & Cardiac Rhythm Management market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Electrocardiogram (ECG) Devices
Implantable Loop Recorders (ILR)
Cardiac Output Monitoring (COM) Devices
Event Monitors
Pacemakers
Cardiac Resynchronization Therapy (CRT) Devices
Defibrillator
External Defibrillator
Ventricular Assist Devices (VADs)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASCs)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardiac Science Corporation
General Electric Company (GE)
Hill-Rom Holdings, Inc.
Jarvik Heart, Inc.
Koninklijke Philips N.V.
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
ReliantHeart Inc.
SCHILLER AG
Abbott
Siemens AG
3M Company
Asahi Kasei Corporation
Stryker Corporation
Mortara Instrument, Inc.
OSI Systems, Inc.
Cardionet Inc.